These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35815768)

  • 1. Helicobacter pylori eradication in elderly patients: can we assume that a bismuth-based therapy is effective as in young people?
    Mladenova I
    Panminerva Med; 2022 Jun; 64(2):289. PubMed ID: 35815768
    [No Abstract]   [Full Text] [Related]  

  • 2. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Zhang W; Chen Q; Liang X; Liu W; Xiao S; Graham DY; Lu H
    Gut; 2015 Nov; 64(11):1715-20. PubMed ID: 26338726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
    Leow AH; Azmi AN; Loke MF; Vadivelu J; Graham DY; Goh KL
    J Dig Dis; 2018 Nov; 19(11):674-677. PubMed ID: 30307122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
    Xie Y; Zhu Z; Wang J; Zhang L; Zhang Z; Lu H; Zeng Z; Chen S; Liu D; Lv N;
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant
    Lee MW; Kim GH
    Gut Liver; 2022 Nov; 16(6):807-808. PubMed ID: 36379903
    [No Abstract]   [Full Text] [Related]  

  • 6. Helicobacter pylori treatment: Still a work in progress.
    Senatore FJ; Wilmot J; Birk JW
    Postgrad Med; 2016 Jan; 128(1):152-7. PubMed ID: 26490697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea.
    Chung JW; Lee GH; Han JH; Jeong JY; Choi KS; Kim DH; Jung KW; Choi KD; Song HJ; Jung HY; Kim JH
    Hepatogastroenterology; 2011; 58(105):246-50. PubMed ID: 21510323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
    Tang D; Yuan L; Yue C; Cai T; Yao Y; Wang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):772-778. PubMed ID: 30124214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of two-week quadruple first-line therapy with bismuth, lansoprazole, amoxicillin, clarithromycin on Helicobacter pylori eradication: a prospective study.
    Ergül B; Doğan Z; Sarikaya M; Filik L
    Helicobacter; 2013 Dec; 18(6):454-8. PubMed ID: 24011287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
    Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
    Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Developments Pertaining to H. pylori Infection.
    Howden CW; Graham DY
    Am J Gastroenterol; 2021 Jan; 116(1):1-3. PubMed ID: 33378314
    [No Abstract]   [Full Text] [Related]  

  • 14. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.
    Demir M; Göktürk S; Oztürk NA; Serin E; Yilmaz U
    Digestion; 2010; 82(1):47-53. PubMed ID: 20410684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Gisbert JP; Gonzalez L; Calvet X
    Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of
    Varga M; Drácz L; Kolbenheyer E; Varga F; Patai ÁV; Solymosi N; Patai Á
    Orv Hetil; 2019 Aug; 160(34):1340-1345. PubMed ID: 31423829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
    Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
    World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
    Janssen MJ; Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2001 May; 15(5):613-24. PubMed ID: 11328254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
    Dehghani SM; Erjaee A; Imanieh MH; Haghighat M
    Dig Dis Sci; 2009 Aug; 54(8):1720-4. PubMed ID: 19005755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
    Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
    Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.